# Vanda Pharmaceuticals Inc – FDA Inspection, Mar 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/vanda-pharmaceuticals-inc/718fbba5-962f-4f9f-94d3-5529997f55a7
Source feed: FDA_Inspections

> FDA inspection 1232759 of Vanda Pharmaceuticals Inc, March 12, 2024. Classification: No Action Indicated (NAI). 2 citations under 21 CFR parts 50 and 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232759
- Company Name: Vanda Pharmaceuticals Inc
- Inspection Date: 2024-03-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1103014 - 2019-09-09

## Related Officers

- [Company Rep](https://www.keypedia.com/people/brittany-l-carpenter/600db4d0-0b6b-435f-b511-2ca10f292d5d)
- [Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)

Company: https://www.keypedia.com/companies/vanda-pharmaceuticals-inc/a60e506d-9654-41ce-a906-98706debec71

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
